Impax Laboratories (IPXL) 8-K/A Financial Statements and Exhibits

Exhibit 23.2

CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-213677, 333-189360, 333-168584 and 333-158259) of Impax Laboratories, Inc. of our report dated October 17, 2016 relating to the special purpose combined financial statements of Certain Pharmaceutical Products of Allergan plc, which appears in this Current Report on Form 8-K/A of Impax Laboratories, Inc.

/s/ PricewaterhouseCoopers LLP

Florham Park, New Jersey

October 17, 2016